Also published in Medical News:
New Melanoma Test May Better Predict Recurrence & Improve Patient Care
x hide permanently

Newer Type 2 Diabetes Medications Have Heart & Kidney Disease Benefits, Too

Medical News

News-Medical.Net

Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease, and cardiometabolic disease believes the medicines should be considered for people with CKD and type 2 diabetes to protect against heart and kidney disease and their serious complications, according to a new Scientific Statement from the American Heart Association, "Cardiorenal Protection With the Newer Antidiabetic Agents ...